Is TB-500 the same thing as thymosin beta-4?

Not exactly, and the distinction matters. "TB-500" is a commercial name used for synthetic peptide products described as related to thymosin beta-4 (Tβ4) — specifically to Tβ4's actin-binding region. A 2026 scoping review found that the large majority of published research (roughly 87.5% of studies reviewed) tested full-length Tβ4 directly, while research specifically testing material labeled "TB-500" was limited to a single study of metabolite profiling and fibroblast screening. The review's authors state the two terms are not interchangeable when the question is whether a specific product has been shown to do anything.

What pathways has published research studied for Tβ4/TB-500?

Animal and cell-culture research has investigated Tβ4's actin-binding mechanism and its role in angiogenesis (new blood-vessel formation), cardiac progenitor cell mobilization after induced heart injury, and connective-tissue organization during wound healing in rodent models. These are studied mechanisms and animal-model observations, not established human effects.

Is there human clinical evidence for TB-500?

No controlled human interventional studies of TB-500 specifically — and none of Tβ4 either — were identified in tendon, ligament, muscle, bone, cartilage, adipose, or spine research categories, according to a 2026 scoping review of 80 studies in this space. Human research on Tβ4 is concentrated instead in ocular/cornea and wound/skin research settings. TB-500 is not an FDA-approved drug.

Is TB-500 legal or regulated?

TB-500 is not FDA-approved for any use and is not a nutritional supplement. The FDA has listed the Tβ4 fragment (LKKTETQ) among bulk drug substances that may present significant safety risks in compounding, citing limited human exposure and safety data, and the World Anti-Doping Agency classifies Tβ4 and its derivatives — including TB-500 — as prohibited substances for athletes.

How does TB-500 compare to BPC-157?

They're related in that both appear in tissue-repair research and are frequently sold together, but they come from different source molecules and are studied through different mechanisms — TB-500/Tβ4 through actin-binding and angiogenesis pathways, BPC-157 through VEGF/nitric-oxide signaling. See TB-500 vs BPC-157: what the research compares.

How is research-grade TB-500 supplied?

Typically as a lyophilized (freeze-dried) powder for reconstitution in a laboratory setting, accompanied by a Certificate of Analysis confirming HPLC-verified purity. A 2026 scoping review specifically flagged that products marketed outside regulated research-supply channels may vary in labeling, composition, and purity.

Materials described here are for laboratory research only and are not for human consumption. Nothing here is medical advice.

October 1, 2026 · Obsessed Living Research Team

TB-500 Research FAQ

Research use only. Not for human consumption.

The Obsessed Living Research Team summarizes peer-reviewed peptide research for educational, research-use reference. Content is not medical advice.

References

The actin binding site on thymosin beta4 promotes angiogenesis
Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization
Thymosin beta4 enhances repair by organizing connective tissue and preventing the appearance of myofibroblasts
Thymosin beta4 and angiogenesis: modes of action and therapeutic potential
Thymosin Beta-4 and TB-500 in Tissue Healing, Regeneration, and Musculoskeletal Repair: A Scoping Review

Research Materials

Related compounds

BPC + TB

Compliance & Disclaimer

This product is supplied strictly for research purposes only. It is not intended for human or animal consumption and is not intended for therapeutic, dietary, cosmetic, diagnostic, or veterinary use.

Statements on this page have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Human/animal consumption prohibited. Laboratory/in-vitro experimental use only.